The EXT1 gene helps make heparan sulfate, a sugar chain that supports normal bone growth and cell-to-cell signaling. This gene plays an important role in shaping cartilage and the ends of growing bones. If the gene does not work properly, people can develop a condition called multiple osteochondromas, with hard bony lumps near joints that may cause pain, changes in limb shape, or limited movement. In some families, a disease-causing variant in the EXT1 gene is the main cause of this inherited bone growth condition.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or to guide activities in the body. Some genes provide the directions for producing proteins, which do the work inside cells. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, more information is available in the LearnHub.
Overview
EXT1Gene function
What if the gene works
The EXT1 gene helps cells make heparan sulfate, a sugar chain that helps cells send and receive signals. This is especially important for normal bone and cartilage growth.
Risk
What if the gene does not work
Variants in the EXT1 gene often cause multiple osteochondromas, with bony growths near joints that can lead to lumps, pain, reduced movement, and altered growth. Milder or more severe variants can influence when features appear and how marked they are.
Treatment
What does that mean for your treatment
No treatment aimed specifically at the EXT1 gene is currently established. Care is based on symptoms, including monitoring bone growths and removing those that cause pain, limit movement, or press on nearby structures. The EXT1 gene is being studied in bone growth pathways, but this has not yet led to a medicine tailored to EXT1.
Conditions associated with EXT1
Gene function
What if the gene works
Many cells rely on the EXT1 gene to build molecules that help them communicate and grow in an organized way. A key job of this gene is making heparan sulfate, a long sugar chain found on the cell surface and in nearby tissues. This supports steady cell function during growth and development.
The EXT1 gene helps cells make heparan sulfate, a long sugar chain attached to certain proteins. Much of this work happens in the Golgi, the cell area that prepares and ships many molecules.
Its protein works closely with the protein from the EXT2 gene to lengthen these sugar chains step by step. This steady teamwork helps cells produce heparan sulfate efficiently.
Heparan sulfate made with help from the EXT1 gene holds and presents many growth signals at the cell surface. This helps nearby cells receive messages at the right place and time.
By shaping these messages, the EXT1 gene supports orderly growth in developing tissues. This is part of what the EXT1 gene does in the body as cartilage, bone, and other structures take shape.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more significantly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the EXT1 gene reduce how well the protein is made or how it works with a partner from the EXT2 gene to build heparan sulfate, a sugar chain that helps cells handle growth signals. In hereditary multiple osteochondromas, this is how EXT1 gene variants affect protein function. Some changes leave partial activity, while more disruptive variants stop the protein early or sharply lower function, which may be linked to earlier or more extensive bone growths.
How variants are linked to conditions
Variants in the EXT1 gene cause hereditary multiple osteochondromas, a condition where a person develops multiple noncancerous bone growths, often near the ends of long bones. The EXT1 gene and hereditary multiple osteochondromas are strongly linked, and finding a disease-causing variant can confirm the diagnosis in someone with matching clinical features. Some people also have short stature, differences in limb shape, pain, or a small lifelong risk of a cartilage related bone cancer.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful EXT1 change, the chance of developing multiple bone growths is largely determined by the variant itself, and it often runs in families. Each child of a parent with an EXT1 variant has a 50% chance of inheriting it. Symptoms can range from mild to more noticeable, and there is not enough evidence to say lifestyle changes lower this risk.
Inheritance of EXT1 variants
For families asking how EXT1 gene variants are inherited, the usual pattern is autosomal dominant. This means a parent with an EXT1-related condition can pass the variant to a child of any sex, and each pregnancy carries a 50% chance of inheriting it. Some people with an EXT1 variant are the first in their family to have it because the variant arose new (de novo) rather than being inherited from either parent.
What does my EXT1 result mean for my family?
For EXT1, a disease-causing result is most often linked to a condition that runs in families in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same gene change. That can matter because family members may have bone growths, short stature, or very mild signs that were never fully explained. Some EXT1 changes happen for the first time in one person, so a parent does not always have to be the source.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the EXT1 gene, doctors use EXT1 genetic testing for hereditary multiple osteochondromas on a blood or saliva sample. A lab reads the gene’s DNA sequence and may also check for missing or extra pieces. Results can show a pathogenic variant, no relevant variant, or a finding that needs more interpretation.
When should I consider getting a genetic test?
Consider testing for the EXT1 gene if you or your child has several noncancerous bone growths, often felt as hard lumps near joints, or if this runs in your family. Testing can help confirm a condition called hereditary multiple osteochondromas and clarify whether close relatives may also carry the gene change.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies gene-drug relationships to help explain why the same treatment can work differently in different people. With many medicines, genes can influence both how much effect a drug has and how the body handles it. Understanding this can support treatment choices that are more informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the EXT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, new symptoms, or whether a treatment is a good fit for you are best discussed with your doctor.
History
Families with multiple bony growths were described long before the EXT1 gene was identified. In the 1990s, researchers mapped one major cause of hereditary multiple osteochondromas to chromosome 8 and then identified the EXT1 gene as a key gene involved in the condition. Building on this early work, scientists found that changes in EXT1 and the related EXT2 gene explained many inherited cases. This helped confirm that what doctors once recognized only by X rays and family patterns had a clear genetic basis. Over time, descriptions became more precise, and EXT1 also gained attention in research on how benign bone growths can rarely change in concerning ways. These discoveries shaped today’s understanding of inherited bone growth conditions.